Substituted Aminothiazoles as Inhibitors of Nucleases

Authors

Paruch, K., Carbain, B., Havel, S., Damborský, J., Brezovský , J., Daniel, L.; Sisáková, A.; Nikulenkov, F., Krejčí, L.

Applicant

Masaryk University, Žerotínovo nám. 9, 601 77 Brno, Czech Republic

Application number

US 11,584,742 B2

Date of submission

2019-04-15

Date of publication

2023-02-21

Abstract

Compounds represented by the structural formula (1) R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Full application EN

Citation

Paruch, K., Carbain, B., Havel, S., Damborský, J., Brezovský , J., Daniel, L.; Sisáková, A.; Nikulenkov, F., Krejčí, L., 2023: Substituted Aminothiazoles as Inhibitors of Nucleases. Masaryk University, Brno, Czech Republic. Patent US 11,584,742 B2.

Pavel’s Research Internship at Chalmers University
Faraneh Earns a Doctoral Degree
Amalie Receives Awards at the Conference of Young Life Scientists
Success at ISBC & ISLS 2026 in Thailand
Press Release: New Algorithm Helps Scientists Reduce Protein Aggregation
Honza Successfully Defends His PhD Thesis
Interview with Naina